Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Oberlin, O"" wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł:
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.
Autorzy:
Grünewald TG; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Bernard V; Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, Paris, France.
Gilardi-Hebenstreit P; École Normale Supérieure (ENS), Institut de Biologie de l'ENS (IBENS), INSERM U1024, CNRS UMR8197, Paris, France.
Raynal V; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.; Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, Paris, France.
Surdez D; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Aynaud MM; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Mirabeau O; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Cidre-Aranaz F; Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.
Tirode F; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Zaidi S; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Perot G; INSERM U916 Biology of Sarcomas, Institut Bergonié, Bordeaux, France.
Jonker AH; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Lucchesi C; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Le Deley MC; Département d'Epidémiologie et de Biostatistiques, Institut Gustave Roussy, Villejuif, France.
Oberlin O; Département de Pédiatrie, Institut Gustave Roussy, Villejuif, France.
Marec-Bérard P; Institute for Pediatric Hematology and Oncology, Leon-Bérard Cancer Center, University of Lyon, Lyon, France.
Véron AS; INSERM U1052, Léon-Bérard Cancer Centre, Cancer Research Center of Lyon, Lyon, France.
Reynaud S; Unité Génétique Somatique (UGS), Institut Curie Centre Hospitalier, Paris, France.
Lapouble E; Unité Génétique Somatique (UGS), Institut Curie Centre Hospitalier, Paris, France.
Boeva V; INSERM U900, Bioinformatics, Biostatistics, Epidemiology and Computational Systems Biology of Cancer, Institut Curie Research Center, Paris, France.; Mines ParisTech, Fontainebleau, France.
Rio Frio T; Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, Paris, France.
Alonso J; Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.
Bhatia S; Institute for Cancer Outcomes and Survivorship, School of Medicine, University of Alabama, Birmingham, Alabama, USA.
Pierron G; Unité Génétique Somatique (UGS), Institut Curie Centre Hospitalier, Paris, France.
Cancel-Tassin G; Centre de Recherche sur les Pathologies Prostatiques (CeRePP)-Laboratory for Urology, Research Team 2, UPMC, Hôpital Tenon, Paris, France.
Cussenot O; Centre de Recherche sur les Pathologies Prostatiques (CeRePP)-Laboratory for Urology, Research Team 2, UPMC, Hôpital Tenon, Paris, France.
Cox DG; INSERM U1052, Léon-Bérard Cancer Centre, Cancer Research Center of Lyon, Lyon, France.
Morton LM; Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, Maryland, USA.
Machiela MJ; Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, Maryland, USA.
Chanock SJ; Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, Maryland, USA.
Charnay P; École Normale Supérieure (ENS), Institut de Biologie de l'ENS (IBENS), INSERM U1024, CNRS UMR8197, Paris, France.
Delattre O; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.; Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, Paris, France.; Unité Génétique Somatique (UGS), Institut Curie Centre Hospitalier, Paris, France.
Pokaż więcej
Źródło:
Nature genetics [Nat Genet] 2015 Sep; Vol. 47 (9), pp. 1073-8. Date of Electronic Publication: 2015 Jul 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bone Neoplasms/*genetics
Early Growth Response Protein 2/*genetics
Oncogene Proteins, Fusion/*genetics
Proto-Oncogene Protein c-fli-1/*genetics
RNA-Binding Protein EWS/*genetics
Sarcoma, Ewing/*genetics
Animals ; Base Sequence ; Bone Neoplasms/pathology ; Carotenoids/genetics ; Cell Line, Tumor ; Cell Proliferation ; Gene Expression ; Gene Expression Regulation, Neoplastic ; Genetic Association Studies ; Genetic Predisposition to Disease ; Humans ; Mice, SCID ; Microsatellite Repeats ; Molecular Sequence Data ; Neoplasm Transplantation ; Oxygenases/genetics ; Polymorphism, Single Nucleotide ; Quantitative Trait Loci ; Sarcoma, Ewing/pathology ; Tumor Burden
Czasopismo naukowe
Tytuł:
Tandem high-dose chemotherapy strategy as first-line treatment of primary disseminated multifocal Ewing sarcomas in children, adolescents and young adults.
Autorzy:
Loschi S; Département de cancérologie de l'enfant et de l'adolescent, Gustave Roussy, Villejuif, France.
Dufour C; Département de cancérologie de l'enfant et de l'adolescent, Gustave Roussy, Villejuif, France.
Oberlin O; Département de cancérologie de l'enfant et de l'adolescent, Gustave Roussy, Villejuif, France.
Goma G; Département de biostatistiques, Gustave Roussy, Villejuif, France.
Valteau-Couanet D; Département de cancérologie de l'enfant et de l'adolescent, Gustave Roussy, Villejuif, France.
Gaspar N; Département de cancérologie de l'enfant et de l'adolescent, Gustave Roussy, Villejuif, France.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Aug; Vol. 50 (8), pp. 1083-8. Date of Electronic Publication: 2015 Jun 01.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Chemoradiotherapy/*methods
Sarcoma, Ewing/*mortality
Sarcoma, Ewing/*therapy
Adolescent ; Adult ; Child ; Child, Preschool ; Disease-Free Survival ; Doxorubicin/administration & dosage ; Etoposide/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Ifosfamide/administration & dosage ; Male ; Survival Rate ; Thiotepa/administration & dosage ; Vincristine/administration & dosage ; Young Adult
Czasopismo naukowe
Tytuł:
Incidence and prognostic value of tumour cells detected by RT-PCR in peripheral blood stem cell collections from patients with Ewing tumour.
Autorzy:
Vermeulen J; Département d'Oncologie Pédiatrique, Institut Curie, Paris, France.
Ballet S
Oberlin O
Peter M
Pierron G
Longavenne E
Laurence V
Kanold J
Chastagner P
Lejars O
Blay JY
Marec-Berard P
Michon J
Delattre O
Schleiermacher G
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2006 Nov 20; Vol. 95 (10), pp. 1326-33. Date of Electronic Publication: 2006 Oct 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Hematopoietic Stem Cell Mobilization/*methods
Hematopoietic Stem Cell Transplantation/*methods
Oncogene Proteins, Fusion/*genetics
Reverse Transcriptase Polymerase Chain Reaction/*standards
Sarcoma, Ewing/*pathology
Transcription Factors/*genetics
Adolescent ; Adult ; Antigens, CD34/analysis ; Bone Marrow Neoplasms/genetics ; Bone Marrow Neoplasms/secondary ; Child ; Child, Preschool ; Disease-Free Survival ; Female ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Humans ; Infant ; Leukapheresis ; Male ; Oncogene Proteins, Fusion/metabolism ; Proto-Oncogene Protein c-fli-1 ; RNA, Messenger/analysis ; RNA-Binding Protein EWS ; Retrospective Studies ; Reverse Transcriptase Polymerase Chain Reaction/methods ; Sarcoma, Ewing/genetics ; Sensitivity and Specificity ; Survival Rate ; Transcription Factors/metabolism ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study).
Autorzy:
Oberlin O; Pédiatrie Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif Cedex, France.
Deley MC
Bui BN
Gentet JC
Philip T
Terrier P
Carrie C
Mechinaud F
Schmitt C
Babin-Boillettot A
Michon J
Pokaż więcej
Corporate Authors:
French Society of Paediatric Oncology
Źródło:
British journal of cancer [Br J Cancer] 2001 Nov 30; Vol. 85 (11), pp. 1646-54.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neuroectodermal Tumors, Primitive, Peripheral/*therapy
Sarcoma, Ewing/*therapy
Adolescent ; Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Child ; Child, Preschool ; Combined Modality Therapy ; Cyclophosphamide/administration & dosage ; Dactinomycin/administration & dosage ; Disease-Free Survival ; Doxorubicin/administration & dosage ; Female ; Humans ; Male ; Neuroectodermal Tumors, Primitive, Peripheral/pathology ; Neuroectodermal Tumors, Primitive, Peripheral/surgery ; Prognosis ; Radiotherapy ; Sarcoma, Ewing/pathology ; Sarcoma, Ewing/surgery ; Time Factors ; Treatment Outcome ; Vincristine/administration & dosage
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies